Medicus Pharma Ltd Stock Retained Earnings
| MDCX Stock | USD 2.54 0.44 20.95% |
Medicus Pharma Ltd fundamentals help investors to digest information that contributes to Medicus Pharma's financial success or failures. It also enables traders to predict the movement of Medicus OTC BB Equity. The fundamental analysis module provides a way to measure Medicus Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medicus Pharma otc bb equity.
| Last Reported | Projected for Next Year | ||
| Retained Earnings | -11.9 M | -12.5 M |
Medicus | Retained Earnings |
Medicus Pharma Ltd Company Retained Earnings Analysis
Medicus Pharma's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current Medicus Pharma Retained Earnings | (10.33 M) |
Most of Medicus Pharma's fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medicus Pharma Ltd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
| Competition |
Based on the latest financial disclosure, Medicus Pharma Ltd has a Retained Earnings of (10.33 Million). This is much lower than that of the Other sector and significantly lower than that of the Other industry. The retained earnings for all United States stocks is notably higher than that of the company.
Medicus Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medicus Pharma's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the otc bb equitys which would be a good addition to a portfolio. Peer analysis of Medicus Pharma could also be used in its relative valuation, which is a method of valuing Medicus Pharma by comparing valuation metrics of similar companies.Medicus Pharma is currently under evaluation in retained earnings category among its peers.
Medicus Fundamentals
| Current Valuation | 26.78 M | ||||
| Price To Earning | (0.21) X | ||||
| Price To Book | 4.65 X | ||||
| EBITDA | (323.24 K) | ||||
| Net Income | (138.89 K) | ||||
| Cash And Equivalents | 1.22 K | ||||
| Total Debt | 103.23 K | ||||
| Current Ratio | 0.53 X | ||||
| Book Value Per Share | (0.13) X | ||||
| Cash Flow From Operations | (65.99 K) | ||||
| Number Of Employees | 15 | ||||
| Beta | 5.96 | ||||
| Market Capitalization | 30.01 M | ||||
| Total Asset | 40.58 K | ||||
| Retained Earnings | (10.33 M) | ||||
| Net Asset | 40.58 K |
About Medicus Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medicus Pharma Ltd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medicus Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medicus Pharma Ltd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Medicus OTC BB Equity Analysis
When running Medicus Pharma's price analysis, check to measure Medicus Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicus Pharma is operating at the current time. Most of Medicus Pharma's value examination focuses on studying past and present price action to predict the probability of Medicus Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicus Pharma's price. Additionally, you may evaluate how the addition of Medicus Pharma to your portfolios can decrease your overall portfolio volatility.